In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
dataset
Tempus, Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas
Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that it was selected by Leidos Biomedical Research Inc. (Leidos Biomed) to abstract and structure follow-up clinical data for The Cancer Genome Atlas (TCGA) Project for submission to the National Cancer Institute’s Genomic Data Commons (GDC).The Cancer Genome Atlas (TCGA) Project BackgroundThere are 230 distinct investigators that contributed
Read More
Blue Cross Blue Shield, BHI Launches Data Innovation Challenge
The Blue Cross Blue Shield Association (BCBSA) and Blue Health Intelligence® (BHI) has announced the launch of the BlueCross BlueShield Data Innovation Challenge to develop solutions that increase access to care, enhance patient engagement, and improve care delivery and outcomes. BCBSA and BHI are collaborating with HIMSS and Healthbox, a HIMSS Innovation company, to implement the BlueCross BlueShield Data Innovation Challenge.BlueCross BlueShield Data Innovation Challenge OverviewTo advance
Read More
Definitive Healthcare Acquires HIMSS Analytics’ Data Services Business
Definitive Healthcare, a provider of data, intelligence, and analytics on the healthcare provider market, announced today that it has acquired the vendor data services business of HIMSS Analytics, which includes the Logic, Predict, Analyze and custom research products. The acquisition will build on the Definitive's articulated growth strategy to deliver the most reliable and consistent view of healthcare data and analytics available in the market.“HIMSS Analytics has developed an extraordinarily
Read More
Precision Health AI Launches Oncology AI Platform Driven by EMR Dataset
Precision Health AI, a healthcare technology company focused on the application of artificial intelligence to cancer care, today announced the launch of the Eureka Health Oncology AI Platform. The 60+ set of pre-trained AI solution modules will utilize Precision Health AI’s proprietary data to predict a patient’s cancer stage, treatment journey, flow through the healthcare system and survival rate.Driving the new Eureka Health Oncology AI platform is Precision Health AI’s deep, longitudinal
Read More
CareSet Labs Releases Next-Gen Medicare Doctor Referral Dataset
CareSet Labs has announced the release of Root NPI Graph, a new version of the “shared Medicare patients in time” provider teaming dataset. The Root NPI graph is the next-generation version of the Doctor Referral teaming dataset commonly available from Medicare. The dataset can be used by data scientists, researchers and innovators including pharmaceutical companies to help decode Medicare claims data to guide new drug launches.Created by Fred Trotter through the Freedom of Information Act
Read More
Mount Sinai Researchers Crowdsource Gene Expression Data for Drug & Target Discovery
Researchers at the Icahn School of Medicine at Mount Sinai have crowdsourced the annotation and analysis of a large number of gene expression profiles from the National Center for Biotechnology Information’s (NCBI) Gene Expression Omnibus (GEO). For the project, more than 70 volunteers from 25 countries helped Mount Sinai researchers analyze the data, enabling the identification of new associations between genes, diseases, and drugs – something that a smaller number of unaided researchers, or an
Read More
